首页 | 本学科首页   官方微博 | 高级检索  
     检索      


An efficient enzymatic preparation of rhinovirus protease inhibitor intermediates
Authors:Carlos A Martinez
Institution:Pfizer Global Research and Development, La Jolla Laboratories, 4215 Sorrento Valley Boulevard, La Jolla, CA 92121, USA
Abstract:The development of an efficient route for the preparation of (2S)-2-3-{(5-methylisoxazol-3-yl)carbonyl]amino}-2-oxopyridin-1(2H)-yl]pent-4-ynoic acid (4), a key intermediate in the synthesis of a human rhinovirus (HRV) protease inhibitor, is presented. In the presence of 40% acetonitrile, the alkaline protease from Bacillus lentus can catalyze the kinetic resolution of racemic ester 7 to afford (S)-acid 4 in 49% chemical yield/per cycle with 98% ee and >98% HPLC purity. The (R)-ester can then be readily recycled via a DBU catalyzed epimerization. The enzymatic preparation described here is superior to the existing chemical resolution route, exhibiting lower costs as well as higher yields, enantioselectivity, and substrate loads. In addition, this protease displays broad substrate specificity toward this class of compounds and can be easily extended to the preparation of other tripeptide mimetics of rhinovirus protease inhibitors.
Keywords:Rhinovirus protease inhibitor  Kinetic resolution  Enzymatic hydrolysis  Process development  Solvent engineering  Bacillus lentus protease  Substrate recycling
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号